A Nomogram Including Total Cerebral Small Vessel Disease Burden Score for Predicting Mild Vascular Cognitive Impairment in Patients with Type 2 Diabetes Mellitus

References

• Rundek T, Tolea M, Ariko T, et al. Vascular Cognitive Impairment (VCI). Neurotherapeutics. 2022;19:68–88. doi:10.1007/s13311-021-01170-y
   PubMed Web of Science ®Google Scholar
• Jia L, Du Y, Chu L, et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health. 2020;5:e661–e671. doi:10.1016/S2468-2667(20)30185-7
   PubMed Web of Science ®Google Scholar
• van der Flier WM, Skoog I, Schneider JA, et al. Vascular cognitive impairment. Nat Rev Dis Primers. 2018;4:18003. doi:10.1038/nrdp.2018.3
   PubMed Web of Science ®Google Scholar
• Iadecola C, Duering M, Hachinski V, et al. Vascular cognitive impairment and dementia: JACC scientific expert panel. J Am Coll Cardiol. 2019;73:3326–3344. doi:10.1016/j.jacc.2019.04.034
   PubMed Web of Science ®Google Scholar
• Lissek V, Suchan B. Preventing dementia? Interventional approaches in mild cognitive impairment. Neurosci Biobehav Rev. 2021;122:143–164. doi:10.1016/j.neubiorev.2020.12.022
   PubMed Web of Science ®Google Scholar
• Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol. 2018;14:591–604. doi:10.1038/s41574-018-0048-7
   PubMed Web of Science ®Google Scholar
• Biessels GJ, Whitmer RA. Cognitive dysfunction in diabetes: how to implement emerging guidelines. Diabetologia. 2020;63:3–9. doi:10.1007/s00125-019-04977-9
   PubMed Web of Science ®Google Scholar
• Srikanth V, Sinclair AJ, Hill-Briggs F, et al. Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities. Lancet Diabetes Endocrinol. 2020;8:535–545. doi:10.1016/S2213-8587(20)30118-2
   PubMed Web of Science ®Google Scholar
• Lyu F, Wu D, Wei C, et al. Vascular cognitive impairment and dementia in type 2 diabetes mellitus: an overview. Life Sci. 2020;254:117771. doi:10.1016/j.lfs.2020.117771
   PubMed Web of Science ®Google Scholar
• Biessels GJ, Strachan MW, Visseren FL, et al. Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions. Lancet Diabetes Endocrinol. 2014;2:246–255. doi:10.1016/S2213-8587(13)70088-3
   PubMed Web of Science ®Google Scholar
• Schnaider BM, Goldbourt U, Silverman JM, et al. Diabetes mellitus in midlife and the risk of dementia three decades later. Neurology. 2004;63:1902–1907. doi:10.1212/01.wnl.0000144278.79488.dd
   PubMed Web of Science ®Google Scholar
• Rawlings AM, Sharrett AR, Albert MS, et al. The association of late-life diabetes status and hyperglycemia with incident mild cognitive impairment and dementia: the ARIC study. Diabetes Care. 2019;42:1248–1254. doi:10.2337/dc19-0120
   PubMed Web of Science ®Google Scholar
• Xu W, Caracciolo B, Wang HX, et al. Accelerated progression from mild cognitive impairment to dementia in people with diabetes. Diabetes. 2010;59:2928–2935.
   PubMed Web of Science ®Google Scholar
• Luo A, Xie Z, Wang Y, et al. Type 2 diabetes mellitus-associated cognitive dysfunction: advances in potential mechanisms and therapies. Neurosci Biobehav Rev. 2022;137:104642. doi:10.1016/j.neubiorev.2022.104642
   PubMed Web of Science ®Google Scholar
• van Sloten TT, Sedaghat S, Carnethon MR, et al. Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression. Lancet Diabetes Endocrinol. 2020;8:325–336. doi:10.1016/S2213-8587(19)30405-X
   PubMed Web of Science ®Google Scholar
• Rensma SP, van Sloten TT, Houben A, et al. Microvascular dysfunction is associated with worse cognitive performance: the maastricht study. Hypertension. 2020;75:237–245. doi:10.1161/HYPERTENSIONAHA.119.13023
   PubMed Web of Science ®Google Scholar
• Jiang C, Wang Y, Dong Y, et al. Associations of microvascular dysfunction with mild cognitive impairment and cognitive function among rural-dwelling older adults in China. J Alzheimers Dis. 2023;93:1111–1124. doi:10.3233/JAD-221242
   PubMed Web of Science ®Google Scholar
• Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822–838. doi:10.1016/S1474-4422(13)70124-8
   PubMed Web of Science ®Google Scholar
• Duering M, Biessels GJ, Brodtmann A, et al. Neuroimaging standards for research into small vessel disease-advances since 2013. Lancet Neurol. 2023;22:602–618. doi:10.1016/S1474-4422(23)00131-X
   PubMed Web of Science ®Google Scholar
• Zhou H, Yang J, Xie P, et al. Cerebral microbleeds, cognitive impairment, and MRI in patients with diabetes mellitus. Clin Chim Acta. 2017;470:14–19. doi:10.1016/j.cca.2017.04.019
   PubMed Web of Science ®Google Scholar
• van Gennip A, Stehouwer C, van Boxtel M, et al. Association of type 2 diabetes, according to the number of risk factors within target range, with structural brain abnormalities, cognitive performance, and risk of dementia. Diabetes Care. 2021;44:2493–2502. doi:10.2337/dc21-0149
   PubMed Web of Science ®Google Scholar
• Choi EY, Park YW, Lee M, et al. Magnetic resonance imaging-visible perivascular spaces in the basal ganglia are associated with the diabetic retinopathy stage and cognitive decline in patients with type 2 diabetes. Front Aging Neurosci. 2021;13:666495. doi:10.3389/fnagi.2021.666495
   PubMed Web of Science ®Google Scholar
• Imamine R, Kawamura T, Umemura T, et al. Does cerebral small vessel disease predict future decline of cognitive function in elderly people with type 2 diabetes? Diabet Res Clin Pract. 2011;94:91–99. doi:10.1016/j.diabres.2011.06.014
   PubMed Web of Science ®Google Scholar
• Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications. Lancet Neurol. 2019;18:684–696. doi:10.1016/S1474-442(19)30079-1
   PubMed Web of Science ®Google Scholar
• Ter Telgte A, van Leijsen E, Wiegertjes K, et al. Cerebral small vessel disease: from a focal to a global perspective. Nat Rev Neurol. 2018;14:387–398. doi:10.1038/s41582-018-0014-y
   PubMed Web of Science ®Google Scholar
• Staals J, Makin SD, Doubal FN, et al. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology. 2014;83:1228–1234. doi:10.1212/WNL.0000000000000837
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–553. doi:10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   PubMed Web of Science ®Google Scholar
• Lu J, Li D, Li F, et al. Montreal cognitive assessment in detecting cognitive impairment in Chinese elderly individuals: a population-based study. J Geriatr Psychiatry Neurol. 2011;24:184–190. doi:10.1177/0891988711422528
   PubMed Web of Science ®Google Scholar
• Skrobot OA, Black SE, Chen C, et al. Progress toward standardized diagnosis of vascular cognitive impairment: guidelines from the vascular impairment of cognition classification consensus study. Alzheimers Dement. 2018;14:280–292. doi:10.1016/j.jalz.2017.09.007
   PubMed Web of Science ®Google Scholar
• Teng Z, Feng J, Dong Y, et al. Triglyceride glucose index is associated with cerebral small vessel disease burden and cognitive impairment in elderly patients with type 2 diabetes mellitus. Front Endocrinol. 2022;13:970122. doi:10.3389/fendo.2022.970122
   PubMed Web of Science ®Google Scholar
• Teng Z, Feng J, Qi Q, et al. Long-term use of metformin is associated with reduced risk of cognitive impairment with alleviation of cerebral small vessel disease burden in patients with type 2 diabetes. Front Aging Neurosci. 2021;13:773797. doi:10.3389/fnagi.2021.773797
   PubMed Web of Science ®Google Scholar
• You Y, Liu Z, Chen Y, et al. The prevalence of mild cognitive impairment in type 2 diabetes mellitus patients: a systematic review and meta-analysis. Acta Diabetol. 2021;58:671–685. doi:10.1007/s00592-020-01648-9
   PubMed Web of Science ®Google Scholar
• Maimaitituerxun R, Chen W, Xiang J, et al. The use of nomogram for detecting mild cognitive impairment in patients with type 2 diabetes mellitus. J Diabetes. 2023;15:448–458. doi:10.1111/1753-0407.13384
   PubMed Web of Science ®Google Scholar
• Zhuang L, Yang Y, Gao J. Cognitive assessment tools for mild cognitive impairment screening. J Neurol. 2021;268:1615–1622. doi:10.1007/s00415-019-09506-7
   PubMed Web of Science ®Google Scholar
• Suain BR, Ariaratnam S, Mat SZ, et al. Cognitive impairment and its associated risk factors in the elderly with type 2 diabetes mellitus. Front Psychiatry. 2021;12:669725. doi:10.3389/fpsyt.2021.669725
   PubMed Web of Science ®Google Scholar
• Zijlmans JL, Lamballais S, Vernooij MW, et al. Sociodemographic, lifestyle, physical, and psychosocial determinants of cognitive reserve. J Alzheimers Dis. 2022;85:701–713. doi:10.3233/JAD-215122
   PubMed Web of Science ®Google Scholar
• Zheng F, Yan L, Yang Z, et al. HbA(1c), diabetes and cognitive decline: the English longitudinal study of ageing. Diabetologia. 2018;61:839–848. doi:10.1007/s00125-017-4541-7
   PubMed Web of Science ®Google Scholar
• Launer LJ, Miller ME, Williamson JD, et al. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol. 2011;10:969–977. doi:10.1016/S1474-4422(11)70188-0
   PubMed Web of Science ®Google Scholar
• Tian S, Han J, Huang R, et al. Increased plasma homocysteine level is associated with executive dysfunction in type 2 diabetic patients with mild cognitive impairment. J Alzheimers Dis. 2017;58:1163–1173. doi:10.3233/JAD-170162
   PubMed Web of Science ®Google Scholar
• Damanik J, Mayza A, Rachman A, et al. Association between serum homocysteine level and cognitive function in middle-aged type 2 diabetes mellitus patients. PLoS One. 2019;14:e224611. doi:10.1371/journal.pone.0224611
   Web of Science ®Google Scholar
• Teng Z, Feng J, Liu R, et al. Cerebral small vessel disease is associated with mild cognitive impairment in type 2 diabetes mellitus. Diabetes Metab Syndr Obes. 2022;15:1985–1994. doi:10.2147/DMSO.S368725
   PubMed Web of Science ®Google Scholar
• Stehouwer C. Microvascular dysfunction and hyperglycemia: a vicious cycle with widespread consequences. Diabetes. 2018;67:1729–1741. doi:10.2337/dbi17-0044
   PubMed Web of Science ®Google Scholar
• Exalto LG, Biessels GJ, Karter AJ, et al. Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study. Lancet Diabetes Endocrinol. 2013;1:183–190. doi:10.1016/S2213-8587(13)70048-2
   PubMed Web of Science ®Google Scholar
• Li CI, Li TC, Liu CS, et al. Risk score prediction model for dementia in patients with type 2 diabetes. Eur J Neurol. 2018;25:976–983. doi:10.1111/ene.13642
   PubMed Web of Science ®Google Scholar